| S. typhimurium TA98+S9 |
S. typhimurium TA100+S9 |
| IQ+antimutagen(s)
dose (mg/plate) |
No of revertants |
±SD |
% of
inhibition |
IQ+antimutagen(s)
dose (mg/plate) |
No of revertans |
±SD |
% of
inhibition |
| 0.1+0 |
1365 |
145 |
|
10+0 |
586 |
104 |
|
| 0.01+0 |
497 |
166 |
|
1+0 |
711 |
79 |
|
| 0.1+0.3EA |
1211 |
194 |
-11 |
10+0.3EA |
577 |
71 |
-2 |
| 0.1+3EA |
1141** |
157 |
-16 |
10+3 EA |
579 |
97 |
-1 |
| 0.1+30EA |
244** |
97 |
-82 |
10+30 EA |
161** |
25 |
-73 |
| 0.1+300EA |
32** |
8 |
-98 |
10+300 EA |
98** |
17 |
-83 |
| 0.1+0.3CRC |
1267 |
197 |
-7 |
10+ 0.3CRC |
588 |
100 |
0 |
| 0.1+3CRC |
1060** |
189 |
-22 |
10+3CRC |
571 |
128 |
-3 |
| 0.1+ 30CRC |
528** |
140 |
-61 |
10+30CRC |
446* |
92 |
-24 |
| 0.1+300CRC |
18** |
4 |
-99 |
10+300CRC |
346** |
109 |
-41 |
| 0.1+0.3EA+0.3CRC |
1195* |
180 |
-13 |
10+0.3EA+0.3CRC |
595 |
100 |
+2 |
| 0.1+3EA+3CRC |
1032** |
192 |
-24 |
10+3EA+3CRC |
465* |
96 |
-21 |
| 0.1+30EA+30CRC |
53**▼ |
31 |
-96 |
10+30EA+30CRC |
151** |
69 |
-74 |
| 0.1+300EA+300CRC |
23** |
5 |
-98 |
10+300EA+300CRC |
83** |
12 |
-86 |
| 0.01+0.3EA |
419 |
179 |
-16 |
1+0.3EA |
619* |
104 |
-13 |
| 0.01+3EA |
416 |
125 |
-16 |
1+3 EA |
609** |
45 |
-14 |
| 0.01+30EA |
66** |
36 |
-87 |
1+ 30 EA |
240** |
79 |
-66 |
| 0.01+300EA |
29** |
5 |
-94 |
1+300 EA |
96** |
19 |
-87 |
| 0.01+0.3CRC |
480 |
149 |
-3 |
1+0.3CRC |
681 |
114 |
-4 |
| 0.01+3CRC |
424 |
127 |
-15 |
1+3CRC |
604** |
113 |
-15 |
| 0.01+30CRC |
187** |
85 |
-62 |
1+ 30CRC |
415** |
79 |
-42 |
| 0.01+300CRC |
25** |
8 |
-95 |
1+300CRC |
163** |
45 |
-77 |
| 0.01+0.3EA+0.3CRC |
363 |
175 |
-27 |
1+0.3EA+0.3CRC |
585** |
129 |
-18 |
| 0.01+3EA+3CRC |
337* |
148 |
-32 |
1+3EA+3CRC |
514**▼ |
69 |
-28 |
| 0.01+30EA+30CRC |
32**▼ |
10 |
-94 |
1+30EA+30CRC |
120**▼ |
22 |
-83 |
| 0.01+300EA+300CRC |
24** |
8 |
-95 |
1+300EA+300CRC |
84** |
9 |
-88 |
| control-DMSO |
28 |
6 |
|
control-DMSO |
83 |
6 |
|
SD standard deviation
*Statistically significant difference between the sample with mutagen and antimutagen(s) and the sample with specific mutagen p < 0.05
**Statistically significant difference between the sample with mutagen and antimutagen(s) and the sample with specific mutagen (1) p < 0.01
▼Statistically significant difference between the sample with combination of antimutagens and samples with specific antimutagens
|
